251 related articles for article (PubMed ID: 11343664)
1. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
Douketis JD; Crowther MA; Foster GA; Ginsberg JS
Am J Med; 2001 May; 110(7):515-9. PubMed ID: 11343664
[TBL] [Abstract][Full Text] [Related]
2. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.
Prandoni P; Lensing AW; Prins MH; Bernardi E; Marchiori A; Bagatella P; Frulla M; Mosena L; Tormene D; Piccioli A; Simioni P; Girolami A
Ann Intern Med; 2002 Dec; 137(12):955-60. PubMed ID: 12484710
[TBL] [Abstract][Full Text] [Related]
3. Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux.
Singh H; Masuda EM
Ann Vasc Surg; 2005 Jan; 19(1):74-9. PubMed ID: 15714371
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis.
Prandoni P; Lensing AW; Bernardi E; Villalta S; Bagatella P; Girolami A;
Thromb Haemost; 2002 Sep; 88(3):402-6. PubMed ID: 12353067
[TBL] [Abstract][Full Text] [Related]
5. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.
Douketis JD; Foster GA; Crowther MA; Prins MH; Ginsberg JS
Arch Intern Med; 2000 Dec 11-25; 160(22):3431-6. PubMed ID: 11112236
[TBL] [Abstract][Full Text] [Related]
6. Inflow thrombosis does not adversely affect thrombolysis outcomes of symptomatic iliofemoral deep vein thrombosis.
Jeyabalan G; Marone L; Rhee R; Hirsch S; Makaroun MS; Cho J; Chaer RA
J Vasc Surg; 2011 Aug; 54(2):448-53. PubMed ID: 21620617
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
10. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
González-Fajardo JA; Martin-Pedrosa M; Castrodeza J; Tamames S; Vaquero-Puerta C
J Vasc Surg; 2008 Oct; 48(4):953-9. PubMed ID: 18639417
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
12. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
13. Use of percutaneous aspiration thrombectomy vs. anticoagulation therapy to treat acute iliofemoral venous thrombosis: 1-year follow-up results of a randomised, clinical trial.
Cakir V; Gulcu A; Akay E; Capar AE; Gencpinar T; Kucuk B; Karabay O; Goktay AY
Cardiovasc Intervent Radiol; 2014 Aug; 37(4):969-76. PubMed ID: 24934734
[TBL] [Abstract][Full Text] [Related]
14. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
[TBL] [Abstract][Full Text] [Related]
15. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment.
Vítovec M; Golán L; Roztocil K; Linhart A
Vasa; 2009 Aug; 38(3):238-44. PubMed ID: 19736635
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of recurrent venous thromboembolism: the role of residual vein thrombosis.
Prandoni P
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):351-3. PubMed ID: 15692242
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.
Birdwell BG; Raskob GE; Whitsett TL; Durica SS; Comp PC; George JN; Tytle TL; Owen WL; McKee PA
Arch Intern Med; 2000 Feb; 160(3):309-13. PubMed ID: 10668832
[TBL] [Abstract][Full Text] [Related]
18. Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis.
Johnson SA; Stevens SM; Woller SC; Lake E; Donadini M; Cheng J; Labarère J; Douketis JD
JAMA; 2010 Feb; 303(5):438-45. PubMed ID: 20124539
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the management of iliofemoral deep vein thrombosis in a resource limited setting: a case series.
Kesieme EB; Okokhere P; Eluehike S; Isabu P
Pan Afr Med J; 2014; 18():254. PubMed ID: 25489359
[TBL] [Abstract][Full Text] [Related]
20. An audit of the clinical and sub-clinical changes in the first year following an acute deep vein thrombosis.
O'Shaughnessy AM; Fitzgerald DE
Int Angiol; 2001 Jun; 20(2):141-7. PubMed ID: 11533522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
